SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer

  1. Van Hazel, G.A.
  2. Heinemann, V.
  3. Sharma, N.K.
  4. Findlay, M.P.N.
  5. Ricke, J.
  6. Peeters, M.
  7. Perez, D.
  8. Robinson, B.A.
  9. Strickland, A.H.
  10. Ferguson, T.
  11. Rodríguez, J.
  12. Kröning, H.
  13. Wolf, I.
  14. Ganju, V.
  15. Walpole, E.
  16. Boucher, E.
  17. Tichler, T.
  18. Shacham-Shmueli, E.
  19. Powell, A.
  20. Eliadis, P.
  21. Isaacs, R.
  22. Price, D.
  23. Moeslein, F.
  24. Taieb, J.
  25. Bower, G.
  26. Gebski, V.
  27. Van Buskirk, M.
  28. Cade, D.N.
  29. Thurston, K.
  30. Gibbs, P.
  31. Erakutsi egile guztiak +
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Argitalpen urtea: 2016

Alea: 34

Zenbakia: 15

Orrialdeak: 1723-1731

Mota: Artikulua

DOI: 10.1200/JCO.2015.66.1181 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak